Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
September 20, 2009
|
September 4, 2009
|
May 20, 2009
|
April 5, 2009
|
|
March 9, 2009
|
February 25, 2009
|
August 27, 2008
|
August 15, 2008
|